Related Experiment Videos
Quinidine-induced ventricular flutter and fibrillation without digitalis therapy
The American Journal of Cardiology
|October 1, 1976
Summary
Quinidine medication can cause dangerous ventricular arrhythmias like flutter and fibrillation. This risk is linked to prolonged Q-T intervals, similar to the Q-T prolongation syndrome.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Quinidine is an antiarrhythmic drug.
- Ventricular arrhythmias are a concern in cardiac patients.
Observation:
- Three cases of ventricular flutter and fibrillation during quinidine use were observed.
- These events occurred without concurrent digitalis therapy.
- Patients received moderate doses of quinidine.
Findings:
- No QRS width changes were noted after quinidine administration.
- Marked prolongation of the Q-T interval was observed.
- The mechanism may resemble that of Q-T prolongation syndrome.
Implications:
- Quinidine use requires careful monitoring for Q-T interval prolongation.
- Understanding this mechanism can inform safer antiarrhythmic drug strategies.
- Further research into quinidine's proarrhythmic effects is warranted.